Maker's videoMMI - Medical Microinstruments, Inc. · 20 Oct 2022
MMI | Connecting Life
Against the record
Symani, from MMI (Medical Microinstruments), is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 4 May 2026: Baptist Health in Jacksonville, Florida did the first operation in a US study (REMIND) testing Symani microsurgery for Alzheimer's and similar brain diseases. The study plans 15 patients.
This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.
From the video's description
‘Connecting Life’ is an important concept for MMI and its employees. It’s our mission to develop, manufacture and market a system that enables surgeons to connect tiny vessels with robotic precision. These connections bring critical blood flow to transferred tissue or bone allowing patients to heal and get back to their lives. Improving access to microsurgery with Symani means that more patients will be treated and able to return to what they love most in their lives. Join us at the crossroads of technology, surgeon skill and innovation to push the boundaries of supermicrosurgery! Connecting Anatomy, Connecting People, Connecting Life.
Written by MMI - Medical Microinstruments, Inc. on YouTube.
More videos of Symani
The Synaptix™ Digital Surgery Platform: Purpose-Built to Enhance Symani®
Robotic-assisted Lymphovenous Bypass for Breast Cancer Related Lymphedema│ A Symani® Patient Story
Symani® Workflow | Robotic-assisted Procedure set-up with the Symani Surgical System
Symani® Surgical System Product Video | Robotic System Overview
MicroChats: Why Robotics in Microsurgery Matters
Robotic-Assisted Breast Reconstruction with Symani | A Connecting the Dots Series Story